Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants

The outbreak of coronavirus disease 2019 (COVID-19) has posed great threats to global health and economy. Several effective vaccines are available now, but additional booster immunization is required to retain or increase the immune responses owing to waning immunity and the emergency of new variant...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Hong, Alu, Aqu, Yang, Jingyun, Ren, Wenyan, He, Cai, Lan, Tianxia, He, Xuemei, Yang, Li, Li, Jiong, Wang, Zhenling, Song, Xiangrong, Wang, Wei, Lu, Guangwen, Wei, Xiawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112270/
https://www.ncbi.nlm.nih.gov/pubmed/35581200
http://dx.doi.org/10.1038/s41392-022-01002-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112270/
https://www.ncbi.nlm.nih.gov/pubmed/35581200
http://dx.doi.org/10.1038/s41392-022-01002-1

Ejemplares similares